Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Oncotelic Therapeutics (OTLC) Other financing activities (2023)

Updated

Analysis

Oncotelic Therapeutics (OTLC) Other financing activities (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,132.10 Bn 1,100.69 Bn 19.71 Bn
2 Johnson & Johnson 615.67 Bn 534.20 Bn 17.26 Bn
3 AbbVie 504.61 Bn 477.72 Bn 12.70 Bn
4 Merck 368.03 Bn 322.41 Bn 12.21 Bn
5 Novartis Ag 298.24 Bn 262.23 Bn 11.24 Bn
6 Astrazeneca 261.77 Bn 235.46 Bn 12.86 Bn
7 Amgen 236.17 Bn 191.57 Bn 7.24 Bn
8 Gilead Sciences 190.62 Bn 164.81 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Oncotelic Therapeutics 8.46 Mn 7.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -25,000.00
Sep 30, 2023 -50,000.00
API Access

Oncotelic Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=OTLC&period=max&api_key=YOUR_API_KEY